CD79A and viral infectious disease: Recent research indicates that secretory IgA confers protective effects for at least 8 months after SARS-CoV-2 infection, indicating durable mucosal immunity.126 Although studies on d-NALT in mice are limited, current research highlights its critical role in viral infection protection.